Context: Wnt1-inducible signaling pathway protein 1 (WISP1) is a novel adipokine participating in adipose tissue (AT) dysfunction; so far, no data on WISP1 in diabetes are available. Objectives: To evaluate plasma WISP1 in subjects with type 2 diabetes (T2D) and its correlates linked to AT inflammation. Design and participants: For this cross-sectional study, 97 consecutive dysmetabolic patients were recruited at the diabetes outpatient clinics of Sapienza University in Rome; 71 of them had T2D, with (n = 35) or without (n = 36) obesity, and 26 were obese patients without diabetes. Twenty-one normal-weight nondiabetic individuals were enrolled as a control group. Study participants underwent clinical workup and blood sampling for metabolic/inflammatory characterization; magnetic resonance imaging (MRI) data on subcutaneous AT and visceral AT (VAT) area, hepatic fat content, and VAT homogeneity were available for most diabetic patients. Results: Plasma WISP1 significantly increased throughout classes of obesity and correlated with greater VAT area, interleukin-8 (IL-8), and lower adiponectin levels, without differing between diabetic and nondiabetic participants. Higher IL-8 was the main determinant of increased WISP1. MRI-assessed VAT inhomogeneity was associated with higher WISP1, IL-8 and C-reactive protein levels, independent of obesity; high WISP1 strongly predicted VAT inhomogeneity (P < 0.001). Conclusions: WISP1 levels are increased in obese persons and are directly related to adiposity, independent of glycemic status or insulin resistance; moreover, they are strongly associated with increased plasma IL-8 and signal abnormalities of VAT. The overall data add insights to the mechanisms underlying metabolic alterations and may open a scenario for innovative therapeutic approaches for diabetes prevention and care.

WISP1 is a marker of systemic and adipose tissue inflammation in dysmetabolic subjects with or without type 2 diabetes / Barchetta, Ilaria; Cimini, Flavia Agata; Capoccia, Danila; De Gioannis, Riccardo; Porzia, Alessandra; Mainiero, Fabrizio; Di Martino, Michele; Bertoccini, Laura; De Bernardinis, Marzia; Leonetti, Frida; Baroni, Marco Giorgio; Lenzi, Andrea; Cavallo, Maria Gisella. - In: JOURNAL OF THE ENDOCRINE SOCIETY. - ISSN 2472-1972. - 1:6(2017), pp. 660-670. [10.1210/js.2017-00108]

WISP1 is a marker of systemic and adipose tissue inflammation in dysmetabolic subjects with or without type 2 diabetes

Barchetta, Ilaria
Primo
;
Cimini, Flavia Agata
Secondo
;
Capoccia, Danila;Porzia, Alessandra;Mainiero, Fabrizio;Di Martino, Michele;Bertoccini, Laura;De Bernardinis, Marzia;Leonetti, Frida;Baroni, Marco Giorgio;Lenzi, Andrea
Penultimo
;
Cavallo, Maria Gisella
Ultimo
2017

Abstract

Context: Wnt1-inducible signaling pathway protein 1 (WISP1) is a novel adipokine participating in adipose tissue (AT) dysfunction; so far, no data on WISP1 in diabetes are available. Objectives: To evaluate plasma WISP1 in subjects with type 2 diabetes (T2D) and its correlates linked to AT inflammation. Design and participants: For this cross-sectional study, 97 consecutive dysmetabolic patients were recruited at the diabetes outpatient clinics of Sapienza University in Rome; 71 of them had T2D, with (n = 35) or without (n = 36) obesity, and 26 were obese patients without diabetes. Twenty-one normal-weight nondiabetic individuals were enrolled as a control group. Study participants underwent clinical workup and blood sampling for metabolic/inflammatory characterization; magnetic resonance imaging (MRI) data on subcutaneous AT and visceral AT (VAT) area, hepatic fat content, and VAT homogeneity were available for most diabetic patients. Results: Plasma WISP1 significantly increased throughout classes of obesity and correlated with greater VAT area, interleukin-8 (IL-8), and lower adiponectin levels, without differing between diabetic and nondiabetic participants. Higher IL-8 was the main determinant of increased WISP1. MRI-assessed VAT inhomogeneity was associated with higher WISP1, IL-8 and C-reactive protein levels, independent of obesity; high WISP1 strongly predicted VAT inhomogeneity (P < 0.001). Conclusions: WISP1 levels are increased in obese persons and are directly related to adiposity, independent of glycemic status or insulin resistance; moreover, they are strongly associated with increased plasma IL-8 and signal abnormalities of VAT. The overall data add insights to the mechanisms underlying metabolic alterations and may open a scenario for innovative therapeutic approaches for diabetes prevention and care.
2017
adipokines; adipose tissue; inflammation; type 2 diabetes; visceral fat
01 Pubblicazione su rivista::01a Articolo in rivista
WISP1 is a marker of systemic and adipose tissue inflammation in dysmetabolic subjects with or without type 2 diabetes / Barchetta, Ilaria; Cimini, Flavia Agata; Capoccia, Danila; De Gioannis, Riccardo; Porzia, Alessandra; Mainiero, Fabrizio; Di Martino, Michele; Bertoccini, Laura; De Bernardinis, Marzia; Leonetti, Frida; Baroni, Marco Giorgio; Lenzi, Andrea; Cavallo, Maria Gisella. - In: JOURNAL OF THE ENDOCRINE SOCIETY. - ISSN 2472-1972. - 1:6(2017), pp. 660-670. [10.1210/js.2017-00108]
File allegati a questo prodotto
File Dimensione Formato  
Barchetta_WISP1_2017.pdf

accesso aperto

Note: https://academic.oup.com/jes/article/1/6/660/3738305?login=true
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 362.54 kB
Formato Adobe PDF
362.54 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1077012
Citazioni
  • ???jsp.display-item.citation.pmc??? 19
  • Scopus 44
  • ???jsp.display-item.citation.isi??? 41
social impact